OVERVIEW

ASCO Direct™ Highlights: 2022 Official Annual Meeting Review is organized by Binaytara Foundation (BTF), American Society of Clinical Oncology (ASCO) and will be held from Jun 18 - 19, 2022 at Grand Hyatt Seattle, Seattle, Washington, United States of America.

Target Audience:
Medical oncologists
Radiation oncologists
• Surgical oncologists
• Oncology residents/fellows
• Oncology NPs/PAs
• Oncology pharmacists
• Oncology nurse

Overview:
This CME-accredited oncology conference, ASCO Direct™ Highlights: 2022 Official Annual Meeting Review, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.  

This oncology conference features some of the most well-known experts in the field of hematology and oncology who will provide a comprehensive overview of noteworthy data presented at the 2022 ASCO Annual Meeting (ASCO2022) in June of 2022. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field and a scientific abstract session. Expert faculty will place abstract findings from ASCO2022 into clinical context and discuss how the results may change the current standard of care. 

Learning Objectives:
At the conclusion of the activity, participants will be able to:
• Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
• Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
• Explain how to effectively manage side-effects associated with cancer treatment
• Review abstracts presented at ASCO® 2022 and discuss their application in clinical settings

KEY DATES

Event Start Date
18 Jun, 2022
Event Start Date
Event End Date
19 Jun, 2022
Event End Date
Credits
  • 11 AMA PRA Category 1 Credits™
  • 11 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantClinical FellowOncologistHealthcare ProfessionalsResidentsNursesHematologistsMedical OncologistSurgical OncologistsRadiation Oncologists

    SPECIALITIES

    OncologyHaematology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationGrand Hyatt Seattle
    721 Pine Street

    TERMS & CONDITIONS

    Notice to HCP's Employed by the Industry:
    If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
    •If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
    •If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

    Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

    Cancellation Policy:
    You may cancel your enrollment at any time. Cancellation fees apply as below:
    • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
    • No refunds will be issued if registration is cancelled after that date.  

    No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235